Tim Welliver

Clinical Development Medical Director at ALX Oncology - Burlingame, California, United States

Tim Welliver's Colleagues at ALX Oncology
Adela Hasa-Moreno

Regulatory Affairs, Associate Director

Contact Adela Hasa-Moreno

Athanasios Tsiatis

Senior Vice President, Clinical Development

Contact Athanasios Tsiatis

Susan Vermeir

Vice President, Regulatory Affairs

Contact Susan Vermeir

Susan Vermeir

VP, Pharmaceutical Regulatory Affairs

Contact Susan Vermeir

View All Tim Welliver's Colleagues
Tim Welliver's Contact Details
HQ
["(353) 161-8000"]
Location
Company
ALX Oncology
Tim Welliver's Company Details
ALX Oncology logo, ALX Oncology contact details

ALX Oncology

Burlingame, California, United States • 11 - 50 Employees
Biotechnology

ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system. ALX Oncology's lead product candidate, evorpacept (also known as ALX148), is a next generation CD47 blocking therapeutic that combines a high-affinity CD47 binding domain with an inactivated, proprietary Fc domain. Evorpacept has demonstrated promising clinical responses across a range of hematologic and solid malignancies in combination with a number of leading anti-cancer agents.

Details about ALX Oncology
Frequently Asked Questions about Tim Welliver
Tim Welliver currently works for ALX Oncology.
Tim Welliver's role at ALX Oncology is Clinical Development Medical Director.
Tim Welliver's email address is ***@alxoncology.com. To view Tim Welliver's full email address, please signup to ConnectPlex.
Tim Welliver works in the Biotechnology industry.
Tim Welliver's colleagues at ALX Oncology are Adela Hasa-Moreno, Connie Lu, Athanasios Tsiatis, Susan Vermeir, Susan Vermeir, Yasmina Abdiche, Danielle Fontaine and others.
Tim Welliver's phone number is ["(353) 161-8000"]
See more information about Tim Welliver